WallStreetZenWallStreetZen

NASDAQ: CNSP
Cns Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CNSP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$17.5M
Current Profit Margin
0%

CNSP Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when CNSP announces earnings.

CNSP Return on Assets

Current Company
-575.4%
Current Industry
3.2%
CNSP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CNSP Return on Capital Employed

Current Company
393.84%
Current Industry
-43.6%
CNSP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNSP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CNSP$0.00-$17.45M-$17.46MN/AN/A
SCNI$0.00-$5.99M-$6.50MN/AN/A
WINT$0.00-$5.32M-$5.96M-100.00%N/A
INM$5.63M-$5.47M-$6.08M+212.88%N/A
SXTP$569.86k$186.86k-$1.01M+20.57%N/A
View Top Biotech Stocks

Cns Pharmaceuticals Earnings & Revenue FAQ

What were CNSP's earnings last quarter?

On Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q1 2024 earnings per share (EPS) of -$0.41, up 84.17% year over year. Total Cns Pharmaceuticals earnings for the quarter were -$3.54 million. In the same quarter last year, Cns Pharmaceuticals's earnings per share (EPS) was -$2.59.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.

What was CNSP's earnings growth in the past year?

As of Q2 2024, Cns Pharmaceuticals's earnings has grown year over year. Cns Pharmaceuticals's earnings in the past year totalled -$17.46 million.

What was CNSP's revenue last quarter?

On Invalid Date, Cns Pharmaceuticals (NASDAQ: CNSP) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cns Pharmaceuticals's revenue was $0.00.

What was CNSP's revenue growth in the past year?

As of Q2 2024, Cns Pharmaceuticals's revenue has grown null year over year. Cns Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.